Investment House LLC’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-48,105
Closed -$3.03M 191
2021
Q2
$3.03M Buy
48,105
+160
+0.3% +$10.3K 0.21% 79
2021
Q1
$4.46M Buy
47,945
+1,160
+2% +$119K 0.34% 66
2020
Q4
$4.19M Buy
46,785
+2,760
+6% +$253K 0.29% 71
2020
Q3
$4.55M Buy
44,025
+3,655
+9% +$394K 0.36% 63
2020
Q2
$3.19M Buy
40,370
+20,830
+107% +$1.55M 0.28% 74
2020
Q1
$1.13M Buy
+19,540
New +$1.13M 0.13% 96

Other funds holding EBS

Investment House LLC's EBS Position: Q3 2021 in Review

Investment House LLC sold out of Emergent Biosolutions (EBS) in Q3 2021, closing a stake of 48,105 shares — an estimated $3.03M sold.

Investment House LLC first reported a position in EBS in Q1 2020 and held it in 6 quarters. The position peaked at $4.55M in Q3 2020. 277 funds tracked by Wall St. Rank hold EBS as of Q3 2021.

  • Investment House LLC reported no remaining Emergent Biosolutions position as of Q3 2021 after selling out during the quarter.
  • Investment House LLC sold 48,105 Emergent Biosolutions shares in Q3 2021, an estimated $3.03M.
  • Investment House LLC first reported a position in Emergent Biosolutions in Q1 2020 and held it in 6 quarters.
  • Investment House LLC's Emergent Biosolutions position peaked at $4.55M in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2021.

Based on Investment House LLC's 13F filing for Q3 2021, filed 12 Nov 2021.